|
Press Conference Schedule
Press conferences will be held in room 303A of the Convention Center (next to the press room). To participate via teleconference, please see below for call-in information. If possible, try to call in up to ten minutes before the call starts.
ALL PRESS MATERIALS AND ABSTRACTS ARE EMBARGOED UNTIL the start of the meeting on Thursday, Oct. 29, at 12:01 a.m. EST, with the exception of research findings presented at IDSA press conferences. Those findings are embargoed until the start of the specific press conference.Press Conferences
Overview Press Conference
10 a.m. ET Thursday, October 29 in Room 303A
This briefing will not be available via teleconference.
Light breakfast will be provided.
Moderators:
Paul G. Auwaerter, M.D., 2009 Annual Meeting Program Chair and Clinical Director of the Division of Infectious Diseases at Johns Hopkins University School of Medicine, Baltimore, Md.
Joel D. Ernst, M.D., 2009 Annual Meeting Vice Chair and Director of the Division of Infectious Disease at New York University School of Medicine, New York, N.Y.
W. Michael Scheld, M.D., 2008 Annual Meeting Program Chair and Professor of Internal Medicine at University of Virginia School of Medicine, Charlottesville, Va.
Back to Top
Influenza Press Conference
11 a.m. ET Thursday, October 29 in Room 303A
To participate by telephone, please call 866-337-6663
To listen to the audio click here.
Abstracts embargoed until the beginning of the press conference.
- When antiviral treatment should – and shouldn’t – be used
- Children infected with H1N1 influenza may shed the virus up to 13 days after they get a fever
- H1N1 vaccine supply availability
Moderator:
Andrew Pavia, M.D., Chair of IDSA's Pandemic Influenza Task Force, Chief of the Division of Pediatric Infectious Diseases, University of Utah
Panelists:
Bruce Gellin, M.D., M.P.H., Director, HHS National Vaccine Program Office
Arnold Monto, M.D., Recipient of IDSA’s 2009 Alexander Fleming Award for Lifetime Achievement and Professor of Epidemiology at the University of Michigan School of Public Health [Award Information]
Richard J. Whitley, M.D., IDSA President-Elect and Director of Pediatric Infectious Diseases at the University of Alabama at Birmingham
Natalie Janine Dailey, M.D., Epidemic Intelligence Service Officer with the North Carolina Division of Public Health Communicable Disease Branch
Achuyt Bhattarai, M.D., Epidemic Intelligence Service Officer with the Centers for Disease Control
Meredith VanderMeer, M.P.H., Oregon Influenza Surveillance Coordinator, Oregon Public Health Division
Highlighted Abstracts:
- #2267 Oseltamivir-resistant 2009 pandemic H1N1 infection among summer camp attendees receiving oseltamivir prophylaxis - North Carolina, 2009 [Full Abstract]
- #2251 Viral shedding patterns of the pandemic influenza A H1N1 virus during an outbreak associated with an elementary school in Pennsylvania, May-June 2009 [Full Abstract]
- #706 Role of statins in preventing death among patients hospitalized with lab-confirmed influenza infections [Full Abstract]
Back to Top
Vaccine Press Conference
Noon ET Thursday, October 29 in Room 303A
To participate by telephone, please call 866-479-6564
To listen to the audio click here.
Abstracts embargoed until the beginning of the press conference.
- Research that shows these unfounded fears exist even among healthcare workers
- Studies that illustrate the huge benefits of maternal flu vaccination, including increasing birthweight and decreasing the risk of premature birth, and among newborns, decreasing the risk of getting sick with the flu and being hospitalized
Also speaking will be international vaccine expert Paul Offit, M.D., who will discuss how to better communicate the importance of vaccination to the public.
Boxed lunches will be available following this press conference.
Moderator:
William Schaffner, M.D., IDSA Board Member and Immunization Work Group Chair, Department of Preventive Medicine, Vanderbilt University Medical Center
Panelists:
Paul Offit, M.D., Center Director of the Vaccine Education Center at Children's Hospital of Philadelphia
Saad B. Omer, MBBS, M.P.H., Ph.D., Assistant Professor of Global Health and Epidemiology, Emory University, Rollins School of Public Health
Mary Anne Jackson, M.D., Chief of Section of Infectious Diseases, Children's Mercy Hospitals and Clinics in Kansas City, Mo.
Marietta Vázquez, M.D., Assistant Professor of Pediatrics at Yale University School of Medicine
Mark C. Steinhoff, M.D., Director of the Global Health Center at Cincinnati Children's Hospital Medical Center
Highlighted Abstracts:
- #703 Impact of maternal immunization against influenza on prematurity and birth weight [Full Abstract]
- #1182 Health care workers attitudes regarding influenza immunization and vaccine receipt [Full Abstract]
- #704 Effectiveness of influenza vaccine given to pregnant women in preventing hospitalization in their infants [Full Abstract]
- #2146 Maternal influenza immunization increases birth weight [Full Abstract]
- #2294 Serologically defined influenza infection in early infancy in South Asia [Full Abstract]
Back to Top
Microbes continue to evolve and develop resistance to treatments. Some of the bugs that are causing the biggest problems currently include methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella, Clostridium difficile and Acinetobacter.
Presentations will include:- Research showing that these bad bugs are increasingly attacking young and healthy people, and that one of the risk factors is taking antibiotics
- Evidence that we’re losing our last line of defense for some Gram negative bacteria – that in some cases we’re down to our last (and very toxic) antibiotic, and that it doesn’t always work
- Data that show newer versions of antibiotics do work, suggesting that we need more incentives to get more drugs in the pipeline, and that we need to practice good stewardship of the antibiotics we do have by using them appropriately
Moderator:
Neil Fishman, M.D., IDSA Antimicrobial Resistance Work Group Chair, Director of the Department of Healthcare Epidemiology and Infection Control and the Director of the Antimicrobial Management Program for the University of Pennsylvania Health System
Panelists:
Brad Spellberg, M.D., IDSA Antimicrobial Availability Task Force Member, Assistant Professor of Medicine at UCLA, and author of “Rising Plague: The Global Threat from Deadly Bacteria and our Dwindling Arsenal to Fight Them”
Fernanda Lessa, M.D., M.P.H., Centers for Disease Control and Prevention
Ghinwa Dumyati, M.D., Associate Professor of Medicine, University of Rochester School of Medicine and Dentistry
Jason Kessler, M.D., Clinical fellow, Division of Infectious Diseases at Columbia University
Karen Jacobson, M.D., Infectious Diseases Fellow at Massachusetts General Hospital, and Brigham and Women’s, Boston, Mass.
Highlighted Abstracts:
- #476 Impact of USA300 methicillin-resistant Staphylococcus aureus (MRSA) infections in clinical outcomes [Full Abstract]
- #994 Clinical features and molecular characterization of community-acquired Clostridium difficile Infections [Full Abstract]
- #903 Changes in susceptibility to polymyxin B amongst clinical specimens in a New York Hospital, 2005-2008 [Full Abstract]
- #2268 Later generation fluoroquinolones (FQ) are associated with improved treatment outcomes for extensively drug-resistant Tuberculosis (XDR TB): A meta-analysis. [Full Abstract]
Related Abstracts:- #869 Seasonality of MRSA Infections - Depends On Where You Look and When You Look [Full Abstract]
- #179 The epidemiology of initial and recurrent Clostridium difficile infections in U.S. hospitals, 2007-2008 [Full Abstract]
- #506 Multidrug resistant acinetobacter – a persistent threat [Full Abstract]
- #2068 An endogenous antimicrobial protein with efficacy against multi-drug resistant gram-negative bacteria: The bactericidal/permeability-increasing protein [Full Abstract]
- #176 Reduction in antimicrobial use following implementation of an electronic medical record associated with a decrease in rate of Clostridium difficile infection at a tertiary-care hospital [Full Abstract]
Back to Top
Global Health Press Conference
9:30 a.m. ET Saturday, October 31 in Room 303A
To participate by telephone, please call 866-337-6663
To listen to the audio click here.
Abstracts embargoed until the beginning of the press conference.
- HIV/tuberculosis (TB) co-infection is a huge problem, but there is more promise in TB drug development than in the past 40 years
- Preventing new infections in the developing world needs to focus on HIV/TB co-infection, and reducing HIV in young women
- Many gains have been made in reducing HIV in children, but more must be done, including identifying and treating HIV-positive pregnant women, and testing infants in the first year of life
Moderator:
Kenneth Mayer, M.D., Co-Chair of the IDSA Center for Global Health Policy's Scientific Advisory Committee, Professor of Medicine at Brown University
Panelists:
William J. Burman, M.D., Infectious Diseases Clinic, Denver, Colo.
Mark F. Cotton, M.D., Ph.D., Stellenbosch University, Matieland, South Africa
Quarraisha Abdool Karim, Ph.D., Centre for the AIDS Programme of Research in Durban, South Africa
Highlighted Presentations:
- TB Treatment in 2019 − How New Drugs will Change the Treatment of an Old Disease
- HIV Pediatric Treatment in the Developing World
- Preventing New HIV Infections in the Developing World
Back to Top
HIV Press Conference
Noon ET Saturday, October 31 in Room 303A
To participate by telephone, please call 866-479-6564
To listen to the audio click here.
Abstracts embargoed until the beginning of the press conference.
- Research suggests a simple change in state laws concerning HIV testing consent requirements could save thousands of lives
- A study shows that people can accurately perform their own HIV tests, suggesting that an over-the-counter test may be available one day
- Research suggests using a unique method that takes the HIV “temperature” of the community can identify areas that are in greatest need of HIV healthcare
And another study being presented shows that HIV-positive people who are overweight are more likely to do poorly.
Moderator:
Mike Saag, M.D., HIV Medicine Association Chair-Elect, Director of the Division of Infectious Diseases at University of Alabama at Birmingham
Panelists:
Charlotte A. Gaydos, M.S., M.P.H, Dr.P.H., Professor of Medicine at Johns Hopkins University
Michael D. April, DPhil, MSc, Harvard Medical School
Moupali Das-Douglas, M.D., M.P.H., Director of Research in HIV Prevention, San Francisco Dept. of Public Health
Nancy F. Crum-Cianflone, M.D., M.P.H., Clinical Research Physician for the Uniformed Services University of the Health Sciences, Bethesda, Md.
Highlighted Abstracts:
- #180 Can we ever expect to have individuals perform their own HIV rapid tests? [Full Abstract]
- #1254 The survival cost of opt-in consent for HIV testing [Full Abstract]
- #1255 Community viral load: geographic, clinical and risk-related disparities in a novel population-based biomarker of HIV prevention and treatment [Full Abstract]
- #342 Obesity among HIV-infected persons: impact of weight on CD4 Cell counts [Full Abstract]
Related Abstracts:- #319 Factors associated with late-diagnosis among African Americans with heterosexually transmitted HIV infection in North Carolina [Full Abstract]
Back to Top
|
